Pan‐Immune‐Inflammation Value Predicts 3‐Month Functional Outcomes in Patients With Acute Ischemic Stroke Treated With Mechanical Thrombectomy
Our study revealed that PIV predicts a poor 3-month prognosis in acute ischemic cerebrovascular disease after MT with a significantly better performance than the widely known systemic immune-inflammation index, systemic inflammation response index, platelet/lymphocyte ratio, and neutrophil/lymphocyte ratio. PIV can be a novel prognostic marker indicating poor prognosis in patients treated with MT.
Authors
- Meltem Karacan Gölen (ORCID: https://orcid.org/0000-0002-2422-9470)
- Keziban Uçar Karabulut (ORCID: https://orcid.org/0000-0001-9188-0266)
- Aynur Yonar (ORCID: https://orcid.org/0000-0003-1681-9398)
- Muhammed Kamiloğlu
Institutions
- Selçuk University (TR)
- Başkent University (TR)
Publication Details
- Journal
- Brain and Behavior
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1002/brb3.70397
- Citations
- 4
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 5.42